J Rhinol.  2021 Jul;28(2):94-101. 10.18787/jr.2021.00357.

Cost-Effectiveness Analysis of Positive Airway Pressure in Patient with Obstructive Sleep Apnea

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Konkuk University, Seoul, Korea

Abstract

Background and Objectives
Positive airway pressure (PAP) is effective at reducing the number of complications in patients with obstructive sleep apnea (OSA). To the best of our knowledge, no cost-effectiveness analysis of PAP has been conducted in Korea.
Subjects and Method
We classified subjects into two groups, those with moderate-to-severe OSA who used PAP after polysomnography (PAP treatment group) and those who did not receive a diagnosis and treatment (control group), and compared their medical expenses over a period of 10 years. The incidence rate of common complications and accidents (coronary heart disease, heart failure, stroke, depression, diabetes, vehicular accidents, and work-related accidents) with or without PAP was adopted through a literature review. The average medical expenses for treating each complication and accident were found by searching several databases. The analysis consisted of a payer’s perspective and a societal perspective.
Results
The incidence of all complications was higher in the control group than in the PAP treatment group. However, since the absolute incidence rate was not high in either group and medical expenses in Korea are low, the expected treatment cost was not high. In contrast, the PAP rental fee was relatively high. To obtain 1 unit of disability-adjusted life year, it costs 40,873,288 won from the payer’s perspective and 31,791,810 won from the societal perspective.
Conclusion
PAP treatment reduces patient complications and extends their lifespan, but costs must be considered.

Keyword

Obstructive sleep apneaㆍCost-effectiveness analysisㆍPositive airway pressure; 폐쇄성수면무호흡증·가격효과분석·양압호흡기

Cited by  1 articles

Cost-Effectiveness Analysis of Uvulopalatopharyngoplasty Versus Positive Airway Pressure in Patient With Obstructive Sleep Apnea in South Korea
Jae Hoon Cho
J Rhinol. 2023;30(1):15-22.    doi: 10.18787/jr.2022.00416.


Reference

References

1. 대한비과학회. 코골이와 수면무호흡증. 아이엠이즈컴퍼니;대한비과학회. 2016.
2. 건강보험요양급여비용. 2020년 3월판. 건강보험심사평가원;2020.
3. 김윤희, 신상진, 박주연, 정예지, 김지민, 이태진 등. 보건의료분야에서 비용 산출방법. 한국보건의료연구원;2013. p.1-181.
4. Guest JF, Panca M, Sladkevicius E, Taheri S, Stradling J. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care. 2014; 37:1263–71.
5. Català R, Villoro R, Merino M, Sangenís S, Colomés L, Hernández Flix S, et al. Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome. Arch Bronconeumol. 2016; 52(9):461–9.
6. Ayas NT, FitzGerald JM, Fleetham JA, White DP, Schulzer M, Ryan CF, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med. 2006; 166(9):977–84.
7. Tan MC, Ayas NT, Mulgrew A, Cortes L, FitzGerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia. Can Respir J. 2008; 15(3):159–65.
8. Streatfeild J, Hillman D, Adams R, Mitchell S, Pezzullo L. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives. Sleep. 2019; 42(12):zsz181.
9. 배준열. 급여화되면 대형병원에 몰릴 줄 알았는데···수면다원검사, 어디서 받았나 봤더니. 의사신문. 2019년 9월 19일. http://www.doctorstimes.com/news/articleView.html?idxno=209022.
10. 요양비의 의료급여기준 및 방법. 제5조의 3(양압치료기). 보건복지부고시 제2020-275호, 2020년 12월 2일 일부 개정.
11. 양압기 요양비 적용 관련 질의응답. 국민건강보험 급여보장실;2018.
12. 2018 도로교통 사고비용의 추계와 평가. 도로교통공단;2019.
13. 2019 근로복지공단 통계연보. 근로복지공단;2020.
14. Chang HS, Kim HJ, Nam CM, Lim SJ, Jang YH, Kim S, et al. The socioeconomic burden of coronary heart disease in Korea. J Prev Med Public Health. 2012; 45(5):291–300.
15. Lee H, Oh SH, Cho H, Cho HJ, Kang HY. Prevalence and socio-economic burden of heart failure in an aging society of South Korea. BMC Cardiovasc Disord. 2016; 16(1):215.
16. 임승지, 김한중, 남정모, 장후선, 장영화, 김세라, 등. 건강보험 청구 자료를 이용한 우리나라 뇌졸중 환자의 사회경제적 비용 추계. Journal of Preventive Medicine and Public Health. 2009; 42:251–60.
17. Chang SM, Hong JP, Cho MJ. Economic burden of depression in South Korea. Soc Psychiatry Psychiatr Epidemiol. 2012; 47(5):683–9.
18. 정현진, 권혜영, 한준태, 김유정, 이애경. 국민건강보험공단 제2형 당뇨 건강검진사업의 비용-효과 분 석. 보건경제와 정책연구. 2008; 14:29–50.
19. 박찬임, 이해춘. 산업재해의 경제적 손실비용 관련 연구: 제조업을 중심으로. 한국노동연구원 연구보고서. 2018 발행.
20. Mansournia MA, Altman DG. Population attributable fraction. BMJ. 2018; 360.
21. Hillman D, Mitchell S, Streatfeild J, Burns C, Bruck D, Pezzullo L. The economic cost of inadequate sleep. Sleep. 2018; 41(8).
22. 홍완기. 공중파에 등장한 ‘의료 저수가’ 문제. 의협신문 2019년 9월 15일.
Full Text Links
  • JR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr